Search results for: Patricia M. Elliott

Professor Nancy Devlin appointed as OHE Senior Visiting Fellow

22 May 2019

…exploration of the trade-offs being made in the allocation of taxation budgets across the public sector (with Patricia Cubí-Mollá and Martin Buxton); research to generate preference-based values for the EQ-5D-Y,…

Why do Immigrants Report Lower Life Satisfaction?

20 July 2017

…and controlling for the potential existence of recall bias. The paper encourages more research on this. Download the full paper here. For more information please contact Patricia Cubi-Molla at OHE….

OHE at the EuroQol Plenary Meeting 2017

26 September 2017

…OHE researchers attended the meeting, playing an active role in both the presentation and discussion of EQ-5D-related research. Patricia Cubi-Molla presented a paper examining the concept of experience-based values. The…

OHE at ISPOR’s 20th Annual European Congress in Glasgow

2 November 2017

…set for Ireland study, led by researchers at NUI Galway. These posters will be presented by Luke Barry and Anna Hobbins. Patricia Cubi-Molla co-authors a poster titled ‘Patients acknowledge adaptation:…

OHE at the EuroQol Academy Meeting 2018

OHE’s Patricia Cubi-Molla, Nancy Devlin, Yan Feng, Mike Herdman, Paula Lorgelly, David Mott, David Parkin and Koonal Shah all contributed to the EuroQol Academy Meeting 2018. The third EuroQol Academy…

OHE at ISPOR 2018

16 May 2018

…preference information in HTA.   Poster: Comparing the EQ-5D-3L and EQ-5D-5L in a Cohort of Cancer Patients   Paula Lorgelly will present this poster – co-authored with OHE’s Patricia Cubi-Molla;…

OHE Conference on Drug Development in 2022: Update

18 July 2012

…Innovations, University of Oxford Professor Sir Alasdair Breckenridge, Chairman of the UK Medicines and Healthcare products Regulatory Agency (MHRA) Professor Patricia Danzon, Celia Moh Professor, Professor of Health Care Management,…

OHE at ISPOR Philadelphia Part 2: Risk Sharing, Medical Breakthroughs, Early Access and Drug Development Costs

12 May 2015

…Washington). Panelists: Adrian Towse (OHE), Joseph DiMasi (Tufts University), Patricia Danzon (University of Pennsylvania).   DiMasi will present new evidence which suggest that drug development costs an average of $2.6…

OHE at ISPOR Europe 2018

…medicines, and the approaches to address them. These challenges risk hindering the availability of life-changing treatments for children with rare diseases. Educational symposium: Indication-based Pricing; Who Wins, Who Loses, and…